Synapse

← The Lancet Regional Health - Europe

Papers in The Lancet Regional Health - Europe

Page 6 · newest first

  1. Time to coronary angiography and revascularization in 575,247 patients with STEMI from 2012 to 2023: a retrospective population-based cohort studyThe Lancet Regional Health - Europe · 2025
  2. Lung aeration and gas exchange in preterm infants developing moderate-to-severe bronchopulmonary dysplasia: a multicentre prospective study from the PATH-BPD cohortThe Lancet Regional Health - Europe · 2026
  3. Viral infections and invasive group a streptococcal disease incidence during 2022–2023The Lancet Regional Health - Europe · 2026
  4. Prioritising meaningful outcomes in the practice evaluation of new chlamydia testing guidelinesThe Lancet Regional Health - Europe · 2026
  5. Management of Parkinson's disease psychosis—a European perspectiveThe Lancet Regional Health - Europe · 2026
  6. Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based studyThe Lancet Regional Health - Europe · 2025
  7. The role of welfare regimes on socioeconomic inequalities in edentulism: a cross-national analysis of 40 countriesThe Lancet Regional Health - Europe · 2025
  8. Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trialThe Lancet Regional Health - Europe · 2025
  9. Parental wealth and mental disorders in Norway (2006–2023): a nationwide registry-based study of 1.4 million young peopleThe Lancet Regional Health - Europe · 2025
  10. Evaluating the effect of probiotics on severe necrotising enterocolitis in preterm infants born before 32 weeks gestation in England and Wales: a propensity-matched population studyThe Lancet Regional Health - Europe · 2025
  11. Anterior cruciate ligament reconstruction combined with anterolateral ligament reconstruction using hamstring autograft versus anterior cruciate ligament reconstruction using bone–patellar tendon–bone autograft: a randomised controlled trial with 5-year follow-upThe Lancet Regional Health - Europe · 2025
  12. Blood culture practices and microbiological capacity for sepsis diagnostics in Europe (2021–2022): a cross-sectional analysis of the European Sepsis Care SurveyThe Lancet Regional Health - Europe · 2025
  13. Effectiveness of an environmental nutrition and physical activity intervention in early childhood education and care settings (NAPSACC UK): a multicentre cluster randomised controlled trialENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2025
  14. Inequalities in availability of clinical trials for pediatric, adolescent, and young adult patients with cancer in Europe: results from the SIOPE OCEAN projectThe Lancet Regional Health - Europe · 2025
  15. Real-world evidence in metabolic dysfunction-associated steatotic liver disease (MASLD): insights, challenges, and future directionsThe Lancet Regional Health - Europe · 2025
  16. Strengthening non-communicable diseases monitoring systems in Europe through a multistakeholder collaborative approach: a key priority for advancing data-driven policymakingThe Lancet Regional Health - Europe · 2025
  17. Patient-reported, psychosocial and health economic outcomes in mild to moderate Friedreich's ataxia: baseline results of the PROFA studyThe Lancet Regional Health - Europe · 2025
  18. Efficacy of an online self-help programme with automated or individualised psychological support versus treatment as usual for caregivers of people with depression: a randomised, controlled, open-label, superiority trialThe Lancet Regional Health - Europe · 2025
  19. Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort studyThe Lancet Regional Health - Europe · 2025
  20. Incidence of community acquired lower respiratory tract disease in Bristol, UK, in 2020–2024: a prospective cohort studyThe Lancet Regional Health - Europe · 2025
  21. Regional inequalities in heart failure hospitalisation and in-hospital mortality in Spain (2016–2022): a nationwide, observational studyThe Lancet Regional Health - Europe · 2025
  22. Sexually transmitted infection testing and key outcomes following implementation of online postal self-sampling into sexual health services in England: a retrospective observational study of routinely collected service-level healthcare dataThe Lancet Regional Health - Europe · 2025
  23. Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort studyThe Lancet Regional Health - Europe · 2025
  24. Promising measures for minimising e-cigarette youth uptake in countries with a significant e-cigarette marketThe Lancet Regional Health - Europe · 2025
  25. COVID-19 Public Health and Social Measures (PHSM) and early childhood developmental concerns in Scotland: an interrupted time series analysisInternational Journal for Population Data Science · 2025
  26. Work ability trajectories and sick leave in individuals with post COVID-19 condition: 3-year follow-up of a population-based cohortThe Lancet Regional Health - Europe · 2025
  27. Current perspectives on psychedelic treatments in EuropeThe Lancet Regional Health - Europe · 2025
  28. Hospital mortality, withdrawal of life-sustaining therapy decisions and early secondary brain insults for critically ill traumatic brain injury patients in England, Wales and Northern Ireland (2009–2024): an observational cohort studyThe Lancet Regional Health - Europe · 2025
  29. Management and Outcomes of Perioperative Care of People with Diabetes across Europe (MOPED): a prospective, observational studyThe Lancet Regional Health - Europe · 2025
  30. Risk of new HIV diagnosis by intersecting migration, socioeconomic, and mental health vulnerabilities in the Netherlands: a nationwide analysis of the ATHENA cohort and Statistics Netherlands registry dataThe Lancet Regional Health - Europe · 2025
  31. Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trialThe Lancet Regional Health - Europe · 2025
  32. Diagnostic algorithms for tuberculosis in Europe: insights from the European Reference Laboratory Network for Tuberculosis (ERLTB-Net)The Lancet Regional Health - Europe · 2025
  33. Frequency and survival of delayed breast cancer diagnosis in women participating at screening mammography in the Netherlands: a population-based studyThe Lancet Regional Health - Europe · 2025
  34. Strengthening antimicrobial resistance governance in Europe: a coordinated one health approachThe Lancet Regional Health - Europe · 2025
  35. Outcomes of adults with community-acquired bacterial meningitis in the Netherlands: a prospective nationwide cohort studyThe Lancet Regional Health - Europe · 2025
  36. Outcomes of adults with community-acquired bacterial meningitis in the Netherlands: a prospective nationwide cohort studyThe Lancet Regional Health - Europe · 2025
  37. A multimodal individualized long-term intervention to prevent functional decline after stroke (LAST-long): a single blinded randomised controlled trialThe Lancet Regional Health - Europe · 2025
  38. Cancer diagnoses, referrals, and survival in people with a learning disability in the UK: a population-based, matched cohort studyThe Lancet Regional Health - Europe · 2025
  39. Estimating future variant Creutzfeldt-Jakob disease cases in the UK: a cohort-based probabilistic modelThe Lancet Regional Health - Europe · 2025
  40. Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysisThe Lancet Regional Health - Europe · 2025
  41. Ending HIV transmission in EuropeThe Lancet Regional Health - Europe · 2025
  42. Percutaneous and surgical management of aortic stenosis in the SWEDEHEART registry (2013–2023): a nationwide observational studyThe Lancet Regional Health - Europe · 2025
  43. Brand-specific influenza vaccine effectiveness in three Nordic countries during the 2024–2025 season: a target trial emulation study based on registry dataThe Lancet Regional Health - Europe · 2025
  44. Suicide after involuntary psychiatric care: a nationwide cohort study in SwedenThe Lancet Regional Health - Europe · 2025
  45. The estimated impact of mandatory front-of-pack nutrition labelling policies on adult obesity prevalence and obesity-related mortality in England: a modelling studyThe Lancet Regional Health - Europe · 2025
  46. Examination of self-harm clustering in adolescent peer networks: a nationwide registry cohort study in FinlandThe Lancet Regional Health - Europe · 2025
  47. Deep inspiration breath-hold for breast cancer radiotherapy: a modelling study of targeted versus non-targeted strategy for clinical and operational optimisationThe Lancet Regional Health - Europe · 2025
  48. Cognitive decline before and after mid-to-late-life continuing education in England: a matched longitudinal analysis of a prospective cohort studyThe Lancet Regional Health - Europe · 2025
  49. Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort studySHILAP Revista de lepidopterología · 2025
  50. Long-acting nitrate use before and after revascularization to evaluate angina in chronic coronary syndrome: a case-crossover study from SCAARThe Lancet Regional Health - Europe · 2025